An overlap syndrome of myasthenia gravis, myocarditis, myositis and hepatitis triggered by immune checkpoint inhibitor use
Authors
Philip Macilwraith
Royal Brisbane and Woman’s Hospital Health Service District: Royal Brisbane and Women’s Hospital, Brisbane, Australia
Darren Ngo
Royal Brisbane and Woman’s Hospital Health Service District: Royal Brisbane and Women’s Hospital, Brisbane, Australia
Hossein Zareie
Royal Brisbane and Woman’s Hospital Health Service District: Royal Brisbane and Women’s Hospital, Brisbane, Australia
Zi-Hao Tan
Royal Brisbane and Woman’s Hospital Health Service District: Royal Brisbane and Women’s Hospital, Brisbane, Australia
Chun Loo Gan
Royal Brisbane and Woman’s Hospital Health Service District: Royal Brisbane and Women’s Hospital, Brisbane, Australia
Language: English
Submitted on: Aug 1, 2024
Accepted on: Nov 24, 2024
Published on: May 18, 2025
Published by: Helenic Society of Medical Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Keywords:
Related subjects:
© 2025 Philip Macilwraith, Darren Ngo, Hossein Zareie, Zi-Hao Tan, Chun Loo Gan, published by Helenic Society of Medical Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.